Search details
1.
HIV viral suppression and risk of viral rebound in patients on antiretroviral therapy: a two- year retrospective cohort study in Northern Tanzania.
BMC Infect Dis
; 24(1): 390, 2024 Apr 11.
Article
in English
| MEDLINE | ID: mdl-38605325
2.
Pharmacokinetic-Pharmacodynamic Determinants of Clinical Outcomes for Rifampin-Resistant Tuberculosis: A Multisite Prospective Cohort Study.
Clin Infect Dis
; 76(3): 497-505, 2023 02 08.
Article
in English
| MEDLINE | ID: mdl-35731948
3.
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis.
Eur Respir J
; 61(3)2023 03.
Article
in English
| MEDLINE | ID: mdl-36328357
4.
Impact of early diagnosis of impaired glucose regulation in tuberculosis: Comparison of clinical outcomes in people with tuberculosis in Tanzania.
Trop Med Int Health
; 27(9): 815-822, 2022 09.
Article
in English
| MEDLINE | ID: mdl-36053910
5.
Therapeutic Drug Monitoring of Anti-infective Drugs: Implementation Strategies for 3 Different Scenarios.
Ther Drug Monit
; 44(1): 3-10, 2022 02 01.
Article
in English
| MEDLINE | ID: mdl-34686647
6.
Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania.
J Clin Microbiol
; 59(4)2021 03 19.
Article
in English
| MEDLINE | ID: mdl-33536294
7.
Gridlock from diagnosis to treatment of multidrug resistant tuberculosis (MDR-TB) in Tanzania: patients' perspectives from a focus group discussion.
BMC Public Health
; 20(1): 1667, 2020 Nov 07.
Article
in English
| MEDLINE | ID: mdl-33160327
8.
Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania.
BMC Infect Dis
; 19(1): 129, 2019 Feb 07.
Article
in English
| MEDLINE | ID: mdl-30732572
9.
Gridlock from diagnosis to treatment of multidrug-resistant tuberculosis in Tanzania: low accessibility of molecular diagnostic services and lack of healthcare worker empowerment in 28 districts of 5 high burden TB regions with mixed methods evaluation.
BMC Public Health
; 19(1): 395, 2019 Apr 11.
Article
in English
| MEDLINE | ID: mdl-30971228
10.
Environmental exposures are important for type 2 diabetes pathophysiology in sub-Saharan African populations.
Diabetologia
; 66(4): 777-779, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36656321
11.
Ethionamide Pharmacokinetics/Pharmacodynamics-derived Dose, the Role of MICs in Clinical Outcome, and the Resistance Arrow of Time in Multidrug-resistant Tuberculosis.
Clin Infect Dis
; 67(suppl_3): S317-S326, 2018 11 28.
Article
in English
| MEDLINE | ID: mdl-30496457
12.
Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis.
Clin Infect Dis
; 67(suppl_3): S293-S302, 2018 11 28.
Article
in English
| MEDLINE | ID: mdl-30496461
13.
d-Cycloserine Pharmacokinetics/Pharmacodynamics, Susceptibility, and Dosing Implications in Multidrug-resistant Tuberculosis: A Faustian Deal.
Clin Infect Dis
; 67(suppl_3): S308-S316, 2018 11 28.
Article
in English
| MEDLINE | ID: mdl-30496460
14.
Improved performance of Xpert MTB/RIF assay on sputum sediment samples obtained from presumptive pulmonary tuberculosis cases at Kibong'oto infectious diseases hospital in Tanzania.
BMC Infect Dis
; 17(1): 808, 2017 12 29.
Article
in English
| MEDLINE | ID: mdl-29284421
15.
Sensititre MycoTB plate compared to Bactec MGIT 960 for first- and second-line antituberculosis drug susceptibility testing in Tanzania: a call to operationalize MICs.
Antimicrob Agents Chemother
; 59(11): 7104-8, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26303804
16.
Therapeutic Drug Monitoring: The Need for Practical Guidance.
Clin Infect Dis
; 68(6): 1065-1066, 2019 03 05.
Article
in English
| MEDLINE | ID: mdl-30219826
17.
Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis.
Antimicrob Agents Chemother
; 58(2): 782-8, 2014.
Article
in English
| MEDLINE | ID: mdl-24247125
18.
Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania.
BMC Infect Dis
; 13: 432, 2013 Sep 14.
Article
in English
| MEDLINE | ID: mdl-24034230
19.
Coinfection of COVID-19 and Tuberculosis in Uganda.
Am J Trop Med Hyg
; 108(6): 1240-1243, 2023 06 07.
Article
in English
| MEDLINE | ID: mdl-37094784
20.
Decision Analytic Modeling for Global Clinical Trial Planning: A Case for HIV-Positive Patients at High Risk for Mycobacterium tuberculosis Sepsis in Uganda.
Int J Environ Res Public Health
; 20(6)2023 03 13.
Article
in English
| MEDLINE | ID: mdl-36981950